cysteine glutathione conjugate - an overview Life Extension Glutathione, Cysteine &
Description
It must be noted, however, that increased GFAP expression and GFAP-positive astrocytic profiles are not always associated with pathology
Solutions: Extend trial to 6 months before concluding inefficacy (some benefits take longer), increase dosing within safe ranges if using lower end, switch peptides (try Cerebrolysin if using BPC-157, or vice versa), add comprehensive eye exam to rule out progression versus peptide failure, consider peptides preventing worsening rather than producing improvement, discontinue if truly no benefit after 6 months rigorous trial
Understanding the role of pathways such as the PPP, which expurgate excessive amounts of ROS, might be crucial for finding an effective treatment against PD
nidulans afforded production of the respective final products
